Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.33 USD
0.00 (1.03%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $0.32 -0.01 (-3.96%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.33 USD
0.00 (1.03%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $0.32 -0.01 (-3.96%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Zacks News
Company News for Jul 13, 2020
by Zacks Equity Research
Companies in the news are: BNGO, AMRX, ALT, EXPR
What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's Why
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).